Blog
RSS FeedPosted by Michael Wonder on 29 Feb 2020
FDA approves first generic of Daraprim
28 February 2020 - Agency continues to support competition in generic drugs, increasing patient access to more affordable medicines. ...
Posted by Michael Wonder on 25 Feb 2020
Perrigo and Catalent announce FDA approval of Perrigo's AB-rated generic version of ProAir HFA
24 February 2020 - Perrigo and its partner, Catalent Pharma Solutions, today announced that the U.S. FDA has approved Perrigo's abbreviated ...
Posted by Michael Wonder on 25 Feb 2020
FDA approves first generic of ProAir HFA
24 February 2020 - Agency supports development of complex generic drugs to improve competition and access to more affordable medicines. ...
Posted by Michael Wonder on 24 Feb 2020
Teva announces FDA approval of ArmonAir Digihaler (fluticasone propionate) inhalation powder
24 February 2020 - Teva’s digital inhaler portfolio now includes products from three of the most commonly prescribed classes of ...
Posted by Michael Wonder on 20 Feb 2020
Serving public health paramount in a successful 2019 for FDA’s generic drug program
19 February 2020 - Safe, effective, high-quality generic drugs play a vital role in the U.S. health care system. ...
Posted by Michael Wonder on 19 Feb 2020
FDA touts generic drug research in 2019
19 February 2020 - The US FDA on Tuesday released a report detailing the scientific research carried out and funded ...
Posted by Michael Wonder on 30 Jan 2020
FDA updates prioritization policy for original abbreviated new drug applications, amendments and supplements to maximise impact on public health
30 January 2020 - Today, the U.S. FDA is making critical updates to our policy for prioritising the review of ...
Posted by Michael Wonder on 16 Jan 2020
U.S. targets drug pricing, no-poach deals for anti-trust action in 2020
15 January 2020 - Justice Department antitrust chief also promises decision on music licensing, criticizes states’ lawsuit against T-Mobile and Sprint. ...
Posted by Michael Wonder on 06 Jan 2020
Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals
3 January 2020 - A federal judge dealt the pharmaceutical industry a setback by declining to block a new California ...
Posted by Michael Wonder on 24 Dec 2019
FDA approves first generics of Eliquis
23 December 2019 - The U.S. FDA has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce ...
Posted by Michael Wonder on 14 Dec 2019
FDA issues new analysis linking greater generic competition and lower generic drug prices
13 December 2019 - Greater competition among generic drug makers is associated with lower generic drug prices, according to a new ...
Posted by Michael Wonder on 10 Dec 2019
Endo launches generic version of Afinitor (everolimus) tablets in the United States
10 December 2019 - Endo International today announced that one of its operating companies, Par Pharmaceutical, has received approval for and ...
Posted by Michael Wonder on 05 Dec 2019
FDA approves first generics of Gilenya
5 December 2019 - The U.S. FDA has approved three applications for first generics of Gilenya (fingolimod) capsules for the ...
Posted by Michael Wonder on 28 Nov 2019
Hikma completes its FDA response for generic Advair
27 November 2019 - Hikma Pharmaceuticals today announces that it has submitted to the US FDA its response to deficiencies in ...
Posted by Michael Wonder on 26 Nov 2019
Teva, drug makers in talks with U.S. to end generics probes
26 November 2019 - Deferred prosecution agreements among resolutions discussed. ...